These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10074590)

  • 1. Cyclosporine disposition and long-term renal function in a 500-pound kidney transplant recipient.
    Flechner SM; Haug M; Fisher RK; Modlin CS
    Am J Kidney Dis; 1998 Oct; 32(4):E4. PubMed ID: 10074590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine pharmacokinetics in renal allograft recipients with diabetes mellitus with Sandimmune and Sandimmune Neoral.
    Serafinowicz A; Gaciong Z; Baçzkowska T; Durlik M; Lao M
    Transplant Proc; 1996 Dec; 28(6):3140-1. PubMed ID: 8962217
    [No Abstract]   [Full Text] [Related]  

  • 3. Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a Neoral-equivalent cyclosporine formulation, using a dose-adjusted method.
    First MR; Weiskittel P; Shah M; Peddi VR; Canafax D; Schroeder TJ
    Transplant Proc; 1998 Dec; 30(8):3955-7. PubMed ID: 9865260
    [No Abstract]   [Full Text] [Related]  

  • 4. Estimation of mean relative bioavailability of cyclosporine Sandimmune and Neoral using NONMEM in renal transplant recipients.
    Lee KL; Lee KT; Chung HM; Lin YP
    Transplant Proc; 1998 Nov; 30(7):3526-9. PubMed ID: 9838545
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine trough levels in diabetic and nondiabetic renal transplant patients.
    Wadhawan S; Jauhari H; Singh S
    Transplant Proc; 2000 Nov; 32(7):1683-4. PubMed ID: 11119891
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine pharmacokinetic profiles in stable renal allograft recipients converting from Sandimmun to Neoral.
    Vathsala A; Lee WT; Jacob E; Woo KT
    Transplant Proc; 1996 Jun; 28(3):1324-6. PubMed ID: 8658678
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine resorption in diabetic patients after simultaneous pancreas and kidney transplantation.
    Storck M; Mickley V; Steinbach G; Abendroth D
    Transplant Proc; 1995 Dec; 27(6):3094-5. PubMed ID: 8539861
    [No Abstract]   [Full Text] [Related]  

  • 8. A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits.
    Etienne I; Toupance O; Bénichou J; Thierry A; Al Najjar A; Hurault de Ligny B; Le Meur Y; Westeel PF; Marquet P; François A; Hellot MF; Godin M
    Nephrol Dial Transplant; 2010 Sep; 25(9):3096-106. PubMed ID: 20299336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring cyclosporine microemulsion at two hours post dosing in pediatric maintenance liver transplant recipients.
    Cambaceres CG; Rojas L; Fernandez MC; Licciardone N; Ferreira O; Diaz A; Moroni A; Moreno AD; Imventarza O
    Transplant Proc; 2010; 42(1):361-2. PubMed ID: 20172350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of cyclosporine malabsorption in diabetic recipients of simultaneous pancreas and kidney transplant using a microemulsion formulation.
    Chapman JR; O'Connell PJ; Bovington KJ; Allen RD
    Transplantation; 1996 Jun; 61(12):1699-704. PubMed ID: 8685946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic analysis of cyclosporine in a renal transplant recipient with congenital absence of the portal vein.
    Nakazawa R; Sato Y; Sasaki H; Shibagaki Y; Kimura K; Chikaraishi T
    Int J Urol; 2015 Aug; 22(8):785-7. PubMed ID: 26041083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients.
    White M; Pelletier GB; Tan A; Jesina C; Carrier M
    J Heart Lung Transplant; 1997 Aug; 16(8):787-94. PubMed ID: 9286770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection?
    el Gamel A; Keevil B; Rahman A; Campbell C; Deiraniya A; Yonan N
    J Heart Lung Transplant; 1997 Mar; 16(3):268-74. PubMed ID: 9087869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion from Sandimmune to Neoral in stable renal and pancreas transplant recipients enhances cyclosporine absorption.
    Chapman JR; O'Connell PJ; Bovington KJ; Allen RD
    Transplant Proc; 1996 Aug; 28(4):2293-5. PubMed ID: 8769229
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic analysis of Neoral conversion in pediatric and adult renal transplant recipients with poor absorption of Sandimmune.
    Pescovitz MD; Henson S; Bodziak K; Book BK; Gonin J; Jindal RM; Leapman SB; Milgrom ML; Filo RS
    Transplant Proc; 1996 Aug; 28(4):2165-8. PubMed ID: 8769189
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of pre-transplant obesity on renal transplant outcomes.
    Drafts HH; Anjum MR; Wynn JJ; Mulloy LL; Bowley JN; Humphries AL
    Clin Transplant; 1997 Oct; 11(5 Pt 2):493-6. PubMed ID: 9361948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of changing from cyclosporine C0 to C2 monitoring in stable recipients following renal transplantation: a prospective cohort study.
    Zhang Y; Zhang XD; Wang Y
    Transplant Proc; 2011 Dec; 43(10):3697-701. PubMed ID: 22172829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen (HLA) B-27 and older age are associated with augmented cyclosporine blood bioavailability in renal allograft recipients: an attempt toward individualization of immunosuppression.
    Nemati E; Taheri S; Pourfarziani V; Einollahi B
    Ann Transplant; 2008; 13(2):32-6. PubMed ID: 18566557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA; Hricik DE; Brinker K; Grinyo JM; Schena FP;
    Transplantation; 2002 Dec; 74(11):1560-7. PubMed ID: 12490789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic profiling of cyclosporine microemulsion during the first 3 weeks after simultaneous pancreas-kidney transplantation.
    Wacke R; Kundt G; Gock M; Klar E; Drewelow B; Schareck W
    Transplant Proc; 2006 Apr; 38(3):751-2. PubMed ID: 16647462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.